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Disorganization of chondrocyte 
columns in the growth plate 
does not aggravate experimental 
osteoarthritis in mice
Ana Lamuedra1, paula Gratal1, Lucía calatrava2,3, Víctor Luis Ruiz‑perez2,3,4, 
Raquel Largo1* & Gabriel Herrero‑Beaumont1
Osteoarthritis (OA) is a multifactorial joint disease mainly affecting articular cartilage (AC) with a 
relevant biomechanical component. During endochondral ossification growth plate (GP) chondrocytes 
arrange in columns. Gps do not ossify in skeletally mature rodents. in neonatal mice, an altered 
joint loading induces Gp chondrocyte disorganization. We aimed to study whether experimental oA 
involves GP disorganization in adult mice and to assess if it may have additional detrimental effects 
on Ac damage. Knee oA was induced by destabilization of the medial meniscus (DMM) in wild‑type 
(Wt) adult mice, and in tamoxifen‑inducible ellis‑van‑creveld syndrome protein (Evc) knockouts 
(EvccKO), used as a model of Gp disorganization due to Hedgehog signalling disruption. chondrocyte 
column arrangement was assessed in the tibial Gp and expressed as column index (ci). Both DMM‑
operated Wt mice and non‑operated‑EvccKO showed a decreased ci, indicating Gp chondrocyte 
column disarrangement, although in the latter, it was not associated to Ac damage. the most severe 
Gp chondrocyte disorganization occurred in DMM‑EvccKO mice, in comparison to the other groups. 
However, this altered Gp structure in DMM‑EvccKO mice did not exacerbate Ac damage. further studies 
are needed to confirm the lack of interference of GP alterations on the analysis of AC employing OA 
mice.
Osteoarthritis (OA) is a joint disease with multifactorial etiology, affecting all joint tissues, specially articular 
cartilage (AC), which progressively undergoes erosion and loss of its mechanical  properties1–3. It is a chronic 
disease associated with  aging4 that displays a low-grade inflammation in the affected joints, causing chronic pain 
and physical and functional  disability2,5. In fact, it is the most frequent and disabling rheumatic pathology, with 
a prevalence of 33% in the population over 65 years of  age2,6. Current treatments relieve some symptoms of the 
disease, such as pain, although they do not alter the natural course of the  disease5. Pathogenic mechanisms of 
tissue damage of a purely mechanical origin coexist with biological processes of inflammatory and proliferative 
 nature7. The etiopathogenic factors responsible for the initiation and progression of OA can be classified into 
three main axes: biomechanical alterations, local low-grade chronic inflammation and the obesity/metabolic 
syndrome  axis5. However, the pathophysiology of OA is still unclear, and preclinical and clinical research is very 
active in order to improve our understanding of the onset and progression of the disease.
A great variety of animal models, from rodents to larger animals, are used, trying to mimic the human disease 
and study its pathogenesis. The mouse model of OA induced by surgical destabilization of the medial meniscus 
(DMM) suitably reflects human OA features, and it is the most commonly selected  approach8–13. The skeletal 
growth of the mouse concludes despite the growth plates (GP) of long bones do not ossify, which impedes the 
fusion of the epiphysis with the  metaphysis9,14–18. This particular characteristic of rodents constitutes a substantial 
difference between these joints and the human ones. However, it has not been described whether this apparently 
minor anatomical feature could in some way call into question some observations in rodent models of OA. In fact, 
around 80% of the studies using mouse models are not reproducible in  humans19. Although the GP disappears 
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in the human adult joint, its particular presence in mice is a relevant fact that demands further research due to 
the extensive use of this experimental model in the study of the pathophysiology of OA.
Limb bone formation occurs through endochondral ossification. In the GP, chondrocytes sequentially align 
as they differentiate. This process is mediated by several synchronized signalling pathways, including Wnt and 
Notch signalling, bone morphogenetic proteins, fibroblast growth factors, insulin-like growth factor 1, and 
the Hedgehog (Hh)–parathyroid hormone-related protein (PTHrP) axis. Hh pathway is especially relevant in 
orchestrating chondrocyte hypertrophy during endochondral ossification. Indian Hedgehog (Ihh) and PTHrP, 
coordinated in time and space, stimulate the proliferation of chondrocytes and delay their differentiation, thus 
preventing premature hypertrophy and ensuring a certain bone  growth20–22. In addition, Ihh-mediated signalling 
Figure 1.  Disorganization of GP chondrocytes during experimental knee osteoarthritis (OA). Destabilization 
of medial meniscus (DMM) was induced in 12 weeks old mice, that were sacrificed 8 weeks after surgery. 
Post-traumatic damage accounted for the articular cartilage (AC) lesions, regarding proteoglycan loss, 
cartilage fibrillation and vertical clefts observed in the AC. (a) Representative mice joint sections stained with 
Safranin-O Fast Green at × 5 and × 20 magnification from non-operated wild type (NO-WT) and DMM-WT 
mice (bars = 250 and 100 µm respectively). (b) Histopathological OARSI Score represented as the sum of 
tibia and femur scores. (c) Representative Haematoxilin-Eosin stained tibia growth plate (GP) sections at × 40 
magnification from NO-WT and DMM-WT mice (bars = 50 µm). (d) Percentage of cells in columns and 
column index (CI) in the GP in NO-WT and DMM-WT mice. Data are shown as median ± interquartile range 
(IQR). (e) Association between the percentage of cells in columns and OARSI score, and between CI and OARSI 
score in WT mice. NO-WT, n = 10–16; DMM-WT, n = 11–12.
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activates the Glioma-Associated Oncogene (GLI) transcription factors, which induce the expression of Runx2 
and promote chondrocyte hypertrophy. Therefore, there is a balance between proliferation and hypertrophy in 
the GP chondrocyte population dependent on negative feedback between Ihh and PTHrP  action21,22.
The primary cilium is a mechanosensing non-motile structure that projects from the cell and plays a cru-
cial role in the transduction of a variety of extracellular signals. After chondrocyte division in the proliferative 
zone, the cilium of the resulting cells orients and cells  polarize23. Then, by successive rotational movements, 
chondrocytes in the GP align parallel to the longitudinal axis of the bone and stack in  columns23. Mutations 
affecting ciliogenesis or the function of proteins anchored to its structure, result in a group of conditions known 
as ciliopathies, many of which include skeletal  phenotypes24. Ellis van Creveld (EvC) syndrome is a ciliopathy 
characterized by disproportionate short stature, short limbs, narrow chest and post-axial polydactyly, among 
other  features24,25. Loss-of-function mutations in EVC and EVC2 cause the EvC syndrome. EVC and EVC2 protein 
products localize at the base of the primary cilium and regulate Hh signal  transduction25.
It has been previously demonstrated that disruption of Hh signalling by Evc deletion alters bone development 
in mice. Evc–/– embryos exhibit shorter proliferative and hypertrophic chondrocyte regions in the GP, and overall, 
shorter bones. Also, Evc–/– mice at postnatal day 16 (P16) show abnormal tibia shape and disorganized epiphyseal 
 chondrocytes26. An altered biomechanical force on chondrocytes during bone development also evokes inac-
curate GP function and defective bone  growth26–28. In neonatal mice, a reduced mechanical joint loading due 
to hemiplegia induces the disorganization of chondrocyte columns in the GP and diminished tibial  length27. 
Similarly, joint immobilization in 6-week-old rats that mimicked an unloading state, reduced the length of the 
tibial GP, resulting in abnormal bone  growth28. In a different approach, in a mouse model of spondyloepiphyseal 
dysplasia congenita, which resulted in an increased mechanical loading on the shoulder, a loss of GP chondrocyte 
column organization in the humerus was  described29.
As chondrocytes in hyaline cartilage have mechanosensors, variations in the pressure of their environment 
can affect the interactions between cells and with the extracellular matrix (ECM).
We aimed to study whether the induction of experimental OA could disturb GP organization in adult mice. 
Moreover, we wanted to assess if GP alteration triggers a further deleterious effect on AC damage. For the latter 
Figure 2.  Effect of GP chondrocyte disarrangement on articular cartilage (AC) in the absence of experimental 
osteoarthritis (OA). (a) Representative Safranin-O Fast Green stained mice joint sections at × 5 and × 20 
magnification in NO-WT and NO-EvccKO mice (bars = 250 and 100 µm respectively). (b) Histopathological 
OARSI Score represented as the sum of tibia and femur scores in NO-WT and NO-EvccKO mice. (c) 
Representative Haematoxilin-Eosin stained tibia growth plate (GP) sections at × 40 magnification in NO-WT 
and NO-EvccKO mice (bars = 50 µm). (d) Percentage of cells in columns and column index (CI) in the GP of 
NO-WT and NO-EvccKO mice. Data are shown as median ± interquartile range (IQR). NO-WT, n = 10–16; 
NO-EvccKO, n = 5.
4
Vol:.(1234567890)




Scientific RepoRtS |        (2020) 10:10745  | https://doi.org/10.1038/s41598-020-67518-0
www.nature.com/scientificreports/
Figure 3.  Effect of GP chondrocyte disarrangement on articular cartilage (AC) (a) Representative Safranin-O 
Fast Green stained mice joint sections at × 5 and × 20 magnification in NO-EvccKO and DMM-EvccKO mice 
(bars = 250 and 100 µm respectively). (b) Histopathological OARSI Score represented as the sum of tibia and 
femur scores in NO-EvccKO and DMM-EvccKO mice. (c) Representative Haematoxilin-Eosin stained tibia growth 
plate (GP) sections at × 40 magnification in NO-EvccKO and DMM-EvccKO mice (bars = 50 µm). (d) Percentage 
of cells in columns and column index (CI) in the GP in NO-EvccKO and DMM-EvccKO mice. (e) Association 
between the percentage of cells in columns and OARSI score, and between CI and OARSI score in EvccKO mice. 
(f) Representative Safranin-O Fast Green stained mice joint sections at × 5 and × 20 magnification in DMM-WT 
and DMM-EvccKO mice (bars = 250 and 100 µm respectively). (g) Histopathological OARSI Score represented 
as the sum of tibia and femur scores in DMM-WT and DMM-EvccKO mice. (h) Representative Haematoxilin-
Eosin stained tibia GP sections at × 40 magnification in DMM-WT and DMM-EvccKO mice (bars = 50 µm). 
(i) Percentage of cells in columns and CI in the GP in DMM-WT and DMM-EvccKO mice. Data are shown as 
median ± interquartile range (IQR). NO-WT, n = 10–16; DMM-WT, n = 11–12; NO-EvccKO, n = 5–6; DMM-
EvccKO, n = 11–12.
▸
purpose, we induced the knee destabilization model of OA to tamoxifen (TAM)-induced Evc knockout mice, 
known to have altered GP chondrocyte organization.
Results
Gp structure is altered during oA. AC damage was evaluated in all joints obtained at sacrifice, 8 weeks 
after DMM surgery. Post-traumatic damage due to surgical DMM accounted for the AC lesions observed in the 
DMM-WT mice, that were characterized by proteoglycan loss, cartilage fibrillation and vertical clefts. Cartilage 
erosions and clefts were mainly located in the bearing region of the tibia (Fig. 1a). As expected, DMM-WT 
mice showed a higher OARSI score than that observed in NO-WT animals (Fig. 1b). We then studied whether 
experimental knee destabilization was able to modify the columnar structure of chondrocytes in the GP. While 
NO-WT mice showed GP chondrocytes arranged in the characteristic columns, DMM-WT mice presented an 
altered columnar structure, and clusters of cells were observed (Fig. 1c). The percentage of cells in columns in 
DMM-WT animals was significantly lower than that found in the NO-WT group, as well as its CI (Fig. 1d). 
We observed a negative association between the percentage of cells in columns and the OARSI score (ρ = -0.55, 
p = 0.01), as well as between the CI and the OARSI score (ρ = -0.52, p = 0.02) (Fig. 1e). In addition, the number 
of columns, the mean column length, the tissue cellularity, and the number of cells per column also decreased in 
the DMM-WT group in comparison to NO-WT animals (Supplementary Fig. S2).
Gp chondrocyte disorganization driven by Evc deletion does not induce Ac damage. In order 
to evaluate whether GP alteration per se could induce OA-like cartilage damage, we employed EvccKO mice. It has 
been previously observed that newborn Evc-/- mice display a clear disarrangement in the  GP26 due to Hh signal-
ling disruption. Therefore, we used adult EvccKO mice, in which both Evc and Evc2 expression were deleted after 
skeletal maturity, as a model of GP disorganization in adult mice. In order to assure that potential AC lesions 
were not caused by bone alterations due to genetic manipulation in EvccKO mice, we first assessed bone growth 
and quality in these mice. EvccKO mice showed no apparent morphological defect and normal skeletal develop-
ment. No differences were observed in the body weight between WT and EvccKO mice at 12 weeks of age, just 
before DMM surgery (Supplementary Fig. S3).
Consequently, we analyzed GP chondrocyte arrangement in NO-EvccKO animals, and observed that this group 
showed a clear GP chondrocyte disorganization in the adult stage (Fig. 2c), with a decreased CI and percentage 
of cells in columns in comparison to NO-WT, (Fig. 2d), as well as a lower GP cellularity, mean column length 
and number of cells per column than those measured in NO-WT mice (Supplementary Fig. S2). Nevertheless, 
NO-EvccKO animals did not show AC damage, and presented a similar OARSI score to that observed in NO-WT 
mice (Fig. 2a,b).
Gp chondrocyte disorganization evoked by Evc deletion does not aggravate Ac damage in a 
DMM‑induced oA model. In order to establish whether GP alteration could accelerate AC damage evoked 
by OA, we studied the GP chondrocyte arrangement and the AC histological damage in DMM-EvccKO mice. The 
pattern of disorganization in the GP chondrocytes due to OA was recurrent among these animals. Accordingly, 
DMM-EvccKO mice showed a significantly lower CI than NO-EvccKO mice, together with a decreased percentage 
of chondrocytes organized in columns, although the latter was not statistically significant (Fig. 3c,d).
As expected, DMM surgery induced significant OA-like lesions in the AC of the EvccKO mice, as it is shown 
in the OARSI score assessment (Fig. 3a,b). As described for WT animals, EvccKO mice also showed a negative 
association between the percentage of cells in columns and the OARSI score (ρ = -0.59, p = 0.02), and between 
the CI and OARSI score (ρ = -0.58, p = 0.02) (Fig. 3e).
DMM-EvccKO mice also showed a lower percentage of cells in columns and a lower CI than that observed in 
DMM-WT mice, exhibiting an absolute loss of chondrocyte organization in the GP (Fig. 3h, i). Additionally, 
cellularity, total number of columns, and number of cells per column were further decreased in DMM-EvccKO 
mice when compared to DMM-WT animals (Supplementary Fig. S2). However, DMM-WT and DMM-EvccKO 
mice exhibited equally severe lesions in the AC, thus showing a similar OARSI score (Fig. 3f, g). Therefore, the 
higher disorganization of the GP observed in the DMM-EvccKO group did not induce additional deleterious effects 
on the AC lesions observed in these animals.
6
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:10745  | https://doi.org/10.1038/s41598-020-67518-0
www.nature.com/scientificreports/
At sacrifice, 8 weeks after DMM surgery, all groups showed identical femur and tibia lengths (Supplementary 
Fig. S3). Furthermore, both cortical and trabecular BMD measured in the femur, tibia and vertebrae, respectively, 
was similar in the four groups studied (Supplementary Fig. S3), indicating a healthy bone growth and devel-
opment in genetically modified animals throughout the study. As expected, we observed an increase in BMD 
in the knee joint of DMM operated animals, which has been described as subchondral bone sclerosis, both in 
 mice30 and in OA  patients31. The increase in knee BMD was similar between DMM-WT and DMM-EvccKO mice 
(Supplementary Fig. S3).
GP COL‑X histological distribution is modified during OA. The GP thickness was similar in NO-WT 
and DMM-WT animals, as well as the proteoglycan content in this localization (Fig. 4a, b). Likewise, there was 
no difference in the amount of MMP-13 and COL-X in the GP between these groups (Fig. 4c–f). However, OA 
accounted for a certain modification in COL-X localization in the GP, as can be observed in Fig. 4e. In NO-WT, 
COL-X was mainly located in the ECM of the upper area, where cells exhibited less COL-X staining when com-
pared to the enlarged hypertrophic chondrocytes in the lower area. In DMM-WT mice, an intense ECM staining 
was observed, and all the cells in the GP seemed to be equally stained (Fig. 4e).
Figure 4.  Assessment of the growth plate (GP) pathological state during osteoarthritis (OA). (a) Representative 
Safranin-O Fast Green stained tibia GP sections at × 40 magnification in NO-WT and DMM-WT mice 
(bars = 50 µm). (b) GP thickness and Safranin-O staining quantification. (c) Representative MMP-13 
immunohistochemistry sections of GP samples (bars = 50 µm). (d) MMP-13 staining quantification. (e) 
Representative COL-X immunohistochemistry sections of GP samples (bars = 50 µm). Black arrows indicate GP 
hypertrophic chondrocytes. (f) COL-X staining quantification. Data are shown as median ± interquartile range 
(IQR). NO-WT, n = 10–16; DMM-WT, n = 12.
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Figure 5.  Evaluation of the growth plate (GP) pathological state in EvccKO mice. (a) Representative Safranin-O 
Fast Green stained tibia GP sections at × 40 magnification in NO-EvccKO mice (bars = 50 µm). (b) Comparison of 
GP thickness and Safranin-O staining quantification in NO-WT and NO-EvccKO mice. (c) Representative MMP-
13 immunohistochemistry of NO-EvccKO GP samples (bars = 50 µm). (d) Comparison of MMP-13 staining 
quantification in NO-WT and NO-EvccKO mice. (e) Representative COL-X immunohistochemistry of NO-EvccKO 
GP samples (bars = 50 µm). (f) Comparison of COL-X staining quantification in NO-WT and NO-EvccKO 
mice. (g) Representative Safranin-O Fast Green stained tibia GP sections at × 40 magnification in DMM-EvccKO 
mice (bars = 50 µm). (h) Comparison of GP thickness and Safranin-O staining quantification in DMM-WT 
and DMM-EvccKO mice. (i) Representative MMP-13 immunohistochemistry of DMM-EvccKO GP samples 
(bars = 50 µm). (j) Comparison of MMP-13 staining quantification in DMM-WT and DMM-EvccKO mice. (k) 
Representative COL-X immunohistochemistry of DMM-EvccKO GP samples (bars = 50 µm). (l) Comparison of 
COL-X staining quantification in DMM-WT and DMM-EvccKO mice. Data are shown as median ± interquartile 
range (IQR). NO-WT, n = 10–16; DMM-WT, n = 12; NO-EvccKO, n = 4–6; DMM-EvccKO, n = 11–12.
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GP proteoglycan content and COL‑X presence are not modified in EvccKO mice. The GP thick-
ness was similar between NO-WT and NO-EvccKO mice, although the GP of these animals seemed to contain a 
higher presence of proteoglycans than that observed in NO-WT (Fig. 5a, b). Both MMP-13 and COL-X stain-
ing and localization were comparable in these groups (Fig. 5c–f). DMM surgery did not seem to modify these 
parameters (Fig. 5g–l).
Gp pathological state may interfere in molecular analyses of Ac damage. Our next objective 
was to assess whether the presence of GP cartilage could disturb the measurement of AC proteins in mouse 
models that employ the femoral condyle for these studies. As can be observed in Supplementary Figure  S4, 
a significant proportion of the hyaline cartilage comes from the GP when the condyle is isolated for analysis. 
Therefore, we analysed the presence of AGG and COL-II, two AC proteins usually analysed in OA studies, in 
mouse condyles with or without AC.
We observed that femoral condyles without AC showed a tendency of lower AGG protein levels compared 
to femoral condyles with intact AC, although no statistical significance was observed (Fig. 6a, b). According to 
these results, a high percentage of total AGG in the mice femoral condyle, around 60–70%, comes from the GP. 
Furthermore, the amount of COL-II protein in the femoral condyles analysed indicates that around 95% of this 
protein comes from the GP cartilage when the condyle is studied, since identical COL-II presence was observed 
in tissues with or without AC (Fig. 6c, d).
Discussion
A relevant percentage of preclinical studies employing animal models are not reproducible in humans, which 
results in a worldwide cost overrun in biomedical  research32,33. For this reason, the search for specific causes 
that may bias the face value of the results and their interpretation emerges mandatory. Our results show that, 
besides the damage in the AC, OA induced by knee destabilization in adult mice altered the characteristic 
columnar structure of the chondrocytes in the GP. Eight weeks after OA induction, columns look shorter and not 
homogenously organized within the GP, but instead, in irregular clusters. Endochondral ossification is an active 
process in mice until 10 week-of-age, when bone development concludes and mice show a mature  skeleton9, even 
though epiphyses do not ossify in skeletally mature rodents as it happens in  humans18. In addition, growing mice 
are resistant to joint  damage9. In order to abolish any effect due to bone immaturity, we studied GP alterations 
Figure 6.  Assessment of growth plate (GP) bias in the molecular analyses of articular cartilage (AC) proteins. 
(a) Protein levels of aggrecan (AGG) in femoral condyles with and without AC of healthy WT mice. (b) Western 
blot analysis of AGG in the mouse femoral condyles. (c) Protein levels of type II collagen (COL-II) in femoral 
condyles with and without AC of healthy WT mice. (d) Western blot analysis of COL-II in the mouse femoral 
condyles. Data are shown as median ± interquartile range (IQR) (n = 10 femora per group).
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induced by joint destabilization in 12-week-old mice, once bone growth was completed. Despite being considered 
a mature GP, our results show that this tissue is profoundly altered by OA in a relatively short period of time. 
Different causes may be responsible for these modifications, although those related to mechanical alterations 
seem of great impact. Limb paralysis in neonatal mice that resulted in a reduced mechanical joint loading, also 
evoked chondrocyte column disorganization at the  GP27. We contemplate that chondrocyte disorganization 
and the loss of the column arrangement during DMM-induced OA might be prompted by an alteration of joint 
biomechanics that results in unbalanced forces. These forces may affect subarticular  tissues34 and even the GP, 
and modify cell-to-cell and cell-to-ECM  interactions35, as well as chondrocyte polarization in the GP.
Both connexins and integrins have been described as mechanotransducers in the cartilage, and modulate cell 
responses after mechanical  stimulation36,37, and could therefore be responsible for the alteration in GP structure 
after joint destabilization. These proteins are especially relevant in chondrocytes, playing an essential role in 
cellular polarity and structure of the collagen network in the GP, and modulating cell-to cell and cell-to matrix 
 interaction37–40. Connexins and integrins can be localized in the chondrocyte primary cilia, where they regulate 
cell interactions with the surrounding  matrix41–43.
Once observed the alteration of chondrocyte columns in the GP induced by OA, we wanted to study whether 
this pathologic disarray could produce AC damage or increase the AC lesions induced by knee destabilization 
in mice. Evc-/- embryos and newborn mice had loss of chondrocyte column structure in the  GP26, together with 
severe skeletal abnormalities that replicate the human disorder described as EvC syndrome. However, most of 
them die a few days after birth or cannot feed  normally26. Here, we have generated a new experimental model for 
conditional Evc deletion in adult mice in order to approach different physio-pathological aspects in  OA26,44. EvccKO 
mice showed no discernible defects neither at 10 weeks of age, not after TAM-induced complete Evc deletion. 
At 10 weeks of age, EvccKO mice showed normal skeletal development, and similar body weight to that observed 
for their WT littermates, in spite of the loss of Evc expression and carrying only one Evc2 allele (unpublished 
data), in line with the skeletal properties described for Evc2+/- heterozygous  mice26,44. TAM administration in 
adult mice predictably induced a complete disruption of Hh signaling, according to previous analyses in Evc-/- 
embryonic  GP26. Adult NO-EvccKO mice did not show any evident skeletal alteration, their tibia and femur length 
were normal, and BMD measurements at different bone locations were similar to those observed for WT mice. 
However, they showed a disorganized GP architecture, with a lesser proportion of chondrocytes in columns to 
that observed in WT animals. This disorganized GP architecture did not predispose to cartilage damage, since 
NO-EvccKO mice did not exhibit any OA-like lesion in the AC. Furthermore, in DMM-EvccKO mice, we observed 
that knee destabilization induced a higher disorganization in the GP to that observed in DMM-WT or in NO-
EvccKO mice, although it did not aggravate AC lesions, which were similar to those observed in DMM-WT 
animals. Therefore, a profound disorganization in the GP did not have any additional detrimental effect on the 
AC. However, it cannot be discarded that a longer monitoring of these animals, resulting in more severe and 
chronic joint instability, could presumably display detectable OA-like cartilage lesions, or even the appearance 
of spontaneous OA.
Since both AC and GP cartilage are damaged during experimental OA, molecular studies using the whole 
mouse femoral condyle could be misinterpreted due to the presence of a damaged GP. The analyses in these 
experimental models are not usually performed by the precise isolation of the AC, due to size limitations. There-
fore, the whole femoral condyle is commonly employed in gene and protein analyses, which may partially contain 
GP cartilage. To elucidate this point, we studied the presence and distribution of classic markers of cartilage 
damage in the GP. While proteoglycan content and MMP-13 presence did not change between healthy and OA 
WT mice, we observed a different distribution pattern of COL-X in the GP during OA. This result guided our 
next experiment considering the possibility that molecular analyses employed as usual markers of hyaline car-
tilage damage may be biased and overestimated by the interference of tissue coming from the GP. We analysed 
whether the relative presence of AGG and COL-II proteins was different in femoral condyles that contain or not 
the AC. In both cases, the origin of the protein was mainly the GP, since the lack of the AC did not significantly 
change the relative presence of these proteins in the femoral condyle analysis. Around 71% AGG and 97% COL-II 
protein may be originated in the GP. Although the contribution of GP cartilage could be variable between the 
different samples, our results showed that molecular analysis of the cartilage in mice samples containing the GP 
should be interpreted with caution.
The limitations of this study include the impossibility of assessing the GP bias on AC during OA, due to the 
unfeasible duplication of the experimental model to obtain the femoral condyles for this purpose.
In conclusion, surgical knee destabilization in mice is responsible for an altered GP structure, accounting 
for chondrocyte disorganization and loss of column arrangement, although this alteration in the GP does not 
predispose nor aggravate the development of more severe damage in AC of the affected joint. AC damage and 
GP disarrangement could be similarly triggered by joint instability, but both seem independent phenomena 
in terms of their progression and underlying mechanisms. Since adult mice exhibit such a great affectation of 
the GP structure, molecular measurements might be overestimated by protein content dragged from the GP 
when employing the whole condyle in order to study AC during OA. Additional research would be necessary 
to determine this interference and its significance in mouse OA model, in order to prevent bias in experimental 
models that may subsequently cause a lack of reproducibility in the human disease.
Methods
Animal model of oA. OA was induced in 12-week old female WT mice by DMM as previously  described8 
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Generation of TAM-induced Evc knockouts was achieved by crossing mice carrying an Evc floxed allele 
(Evcflox/+)44 with UBC-CreERT2 (Tg.hUBC-CreERT2)  transgenics45. Male offspring of these crosses that were 
heterozygous for both CreERT2 and the Evc floxed allele were subsequently mated to females heterozygous for 
an Evc null allele (Evc+/-)26 to obtain Evcflox/-;UBC-CreERT2 mice. The generation of the Evc floxed allele and the 
Evc null allele have previously been described by Caparros-Martin et al. and Ruiz-Perez et al.  respectively26,44. Of 
note, the Evc floxed allele is also null for Evc2 (Supplementary Fig. S1)26. Mice were maintained in a C57BL/6;129 
mixed background. At 10 weeks of  age9, Evcflox/-;UBC-CreERT2+/- female mice received 0.075 mg/g/day TAM 
administered in five intraperitoneal injections. These mice will be referred to as EvccKO and were used as a model 
of chondrocyte disorganization in the GP. OA was induced in 12-weeks old EvccKO mice by DMM (DMM-EvccKO, 
n = 12 joints), while non-operated EvccKO mice were simultaneously followed (NO-EvccKO, n = 6 joints).
EvccKO littermates that were genotyped with Evc and Evc2 WT alleles were used as WT animals in the OA 
model.
Eight weeks following DMM surgery, all mice were anesthetized and bone mineral density (BMD) was 
assessed by dual-energy X-ray absorptiometry using PIXImus (GE Lunar Corp., USA). Afterwards, mice were 
euthanized and knee joints fixed in 4% formaldehyde (Sigma-Aldrich, USA), decalcified and embedded in par-
affin for histopathological analyses (Supplementary Fig. S1). Animal handling, experimental protocol PROEX 
119/16 and all methods complied with Spanish Regulations and the Guidelines for the Care and Use of Labora-
tory Animals drawn up by the National Institutes of Health (Bethesda, MD, USA). Experimental protocols were 
approved by the Institutional Ethics and Welfare Committees of the IIS-Fundación Jiménez Díaz and Alberto 
Sols Biomedical Research Institute.
Analysis of the interference of Gp cartilage proteins in the study of Ac proteins. Fifteen 
3-month-old female C57BL/6 WT mice were euthanized and the femurs were dissected. The AC from left femo-
ral condyles was scraped with a surgical scalpel until completely removed, while right femora were kept intact. 
Femoral condyle samples from 10 mice were immediately frozen in liquid  N2 for protein analysis, while the 
remaining 5 samples were fixed in 4% formaldehyde (Sigma-Aldrich), decalcified and embedded in paraffin for 
histological analyses.
Gp chondrocyte column organization assessment. The analysis of the GP chondrocyte column 
organization was performed in the knee sections obtained eight weeks after DMM surgery from operated 
and non-operated animals. 4 µm sagittal paraffin-embedded knee sections were stained with Haematoxylin–
Eosin. Joint sections were photographed with a Leica DM3000 LED digital micro-imaging instrument (Leica, 
Microsystems, Inc. Buffalo Grove, IL, USA) at the central region of the tibia at × 40 magnification, and chondro-
cyte histomorphometry was evaluated as described  elsewhere27,46. Briefly, a chondrocyte column was defined as 
a chondron containing a minimum of three chondrocytes, located no more than 20 pixels apart one from each 
other, and with angles between them ranging from -155° to -179° or 155° to 180°. These parameters were com-
puted as previously described by Killion et al27. Once the columns were established in each sample, the number 
of cells was quantified using the Image J Software (NIH, USA) cell counter plug-in. Then, the percentage of cells 
in columns was obtained by calculating the ratio ‘cells in columns’/ ‘total cells in the GP’. Column Index (CI) was 
calculated multiplying the percentage of cells in columns by their respective  length27.
Histopathological assessment of the cartilage. AC was evaluated in 4 µm sagittal knee joint sections 
that were stained with Safranin-O Fast Green. The histological damage was assessed by two blinded observers 
following the OARSI recommendations for mice  samples47, which were adapted for sagittal slices. The semi-
quantitative 0 to 6 points scoring system was applied to one area in the femur and one area in the tibia, and the 
sum of these two scores was represented as the total score.
Proteoglycan content in the GP cartilage was also evaluated in Safranin-O Fast Green stained joint samples. 
Sections were photographed with a Leica DM3000 LED digital micro-imaging instrument (Leica, Microsystems, 
Inc. Buffalo Grove, IL, USA) at the central region of the tibia at × 40 magnification. Specific Safranin-O staining 
in the femur and tibia GP, as well as GP thickness, were measured employing Image J software, and corrected 
by sample area.
immunohistochemical analysis. 4 µm knee joint sections were deparaffinized and rehydrated. Antigen 
retrieval was performed by incubation with 20 µg/mL proteinase K (Promega, USA). Tissue sections were pro-
cessed as previously  described48–50, and then incubated with the corresponding primary antibody: anti-mouse 
type X collagen (COL-X) (1/2000; ab58632, Abcam, UK) or anti-metalloproteinase (MMP)-13 (1/200; ab39012; 
Abcam). A secondary biotinylated anti-rabbit IgG was used for detection of positive signal through a horseradish 
peroxidase linked to an avidin/biotin complex (ABC) (Vector Laboratories, USA) using 3,3 diaminobenzidine 
tetra-hydrochloride as chromogen (Dako, Denmark). Joint sections were counterstained with Haematoxylin, 
dehydrated and mounted in DPX (Merck Millipore, USA). Sections were photographed with a Leica DM3000 
LED digital micro-imaging instrument (Leica, Microsystems, Inc. Buffalo Grove, IL, USA) at the central region 
of the tibia at × 40 magnification, and specific staining in the GP was quantified using Image J software and cor-
rected by sample area.
Dual‑energy X‑ray absorptiometry. BMD (g/cm2) was assessed eight weeks after surgery in anesthe-
tized mice, by dual-energy X-ray absorptiometry (DXA) using PIXImus (GE Lunar Corp., USA), as previously 
 described51. BMD was assessed in different regions of interest (ROIs). For subchondral BMD, we employed a 
11 × 11 pixel ROI focused on the knee joint; cortical BMD was measured in the femur and in the tibia employ-
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ing a 17 × 13 pixel ROI; and trabecular bone BMD was evaluated on L2 and L3 lumbar vertebrae employing a 
35 × 23 pixel ROI. Images were scaled according to the PIXImus phantom size, and femur and tibia lengths were 
measured employing the Image J software.
Western blot. Briefly, 20  μg of total protein from tissues were extracted as described  elsewhere50, sepa-
rated by electrophoresis in SDS–polyacrylamide gels and transferred to a nitrocellulose membrane in a semi-
dry Trans-Blot device (Bio-Rad, Madrid, Spain). The following primary antibodies were applied: anti-mouse 
aggrecan (AGG) antibody (1/100; ab3778; Abcam) and anti-mouse type II collagen (COL-II) antibody (1/1,000; 
ab34712; Abcam) in 3% BSA, overnight at 4 °C. The binding signal was detected by chemiluminescence using 
Horseradish Peroxidase-linked secondary antibodies. EZBlue gel staining reagent (Sigma-Aldrich) was used for 
tissue protein loading control. Densitometric measurements were normalized relative to total protein presence 
in femoral condyles with AC using Quantity One software (Bio-Rad) and expressed as arbitrary densitometric 
units (A.U.)49,50,52.
Statistical analysis. Each limb was considered as an independent sample. Based on previously published 
 data27,48, the sample size was determined on the expected difference to be detected regarding the percentage of 
cells in columns. By accepting a significance level (alpha) of 5%, and a statistical power of 80%, a pairwise t-test 
between conditions requires 6 limbs per group to demonstrate an approximate 35% change (70 vs 25) assuming a 
standard deviation of 5, calculated using the G-power 3.1 software (G-power, Germany)53. Owing to the genera-
tion limitations for EvccKO mice, the required number of samples obtained by statistical prediction was assigned 
to the NO-EvccKO group (n = 6 limbs). The n was tripled for the DMM-EvccKO group (n = 18 limbs), to ensure the 
required number in case of unexpected deaths. During surgery two mice died due to a defective assimilation 
of anaesthesia, and another one shortly after surgery, remaining n = 12 limbs. The n assigned to NO-WT and 
DMM-WT groups was 16 limbs, due to lack of survival limitations. However, two mice died a few days after 
surgery, remaining 12 limbs in the DMM-WT group.
No adjustment for multiple comparisons between groups was made a priori, but to preserve type one error, 
individual tests were only undertaken following a significant omnibus ANOVA test. Non-parametric tests were 
used due to a lack of normality based on a Kolmogorov–Smirnov test. Kruskal–Wallis test was used for compari-
sons between multiple groups prior to Mann–Whitney U-test for comparisons between two groups, adopting 
a Bonferroni correction. A P-value of less than 0.05 was considered statistically significant. Associations were 
expressed using Spearman’s rank correlation coefficient (rho, ρ). Statistical analyses of data were performed 
using GraphPad Prism 6.01 for Windows (GraphPad Software, USA). Data were expressed as median with 
interquartile range (IQR).
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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